Management Commentary. Xxxx X. Xxxx, Chief Executive Officer of Kindred, said, “Over the last eight weeks, we undertook a robust due diligence process and worked closely and constructively with our counterparts at Gentiva to better understand their operations, financial results and outlook. This process confirmed the compelling strategic rationale and industrial logic of this combination, as well as our belief that this transaction is in the best interests of both companies and our respective shareholders, patients, employees and business partners. This significantly accretive transaction will generate strong operating cash flows that will allow Kindred to quickly delever and support future growth and return of capital to shareholders. We look forward to bringing our two companies together to advance our strategy, mission and shared values.”
Management Commentary. Commenting on the Agreement with Newmont, Prodigy Gold’s Managing Director Xxxx Xxxxxx said:
Management Commentary. Prodigy Gold Managing Director, Xxxx Xxxxxx, commented: “We are very pleased to be partnering with the world’s largest gold miner to fast-track the exploration of our Tobruk Project in the Tanami Province, a region which is considered the exploration destination of choice for several major gold producers.” “Newmont Goldcorp has a long and successful history in the Tanami area including developing the nearby Xxxxxx Gold Mine into a world-class gold deposit and we are looking forward to leveraging Newmont Goldcorp’s extensive technical knowledge as work gets underway at Tobruk this quarter.” “Prodigy Gold now has in excess of A$33M in funding agreements from JV partners to accelerate discovery across the Company’s entire exploration portfolio, including JV’s with Independence Group (70/30) and Newcrest Mining (earn-in stage) that have already generated high-quality targets which are currently being drilled.” “Further, we remain committed to unlocking the value of our 100%-owned projects and the cash payment received from Newmont Goldcorp as entry into the Tobruk JV allows this strategy to continue at pace.”
Management Commentary. Targets and expectations for the year ahead This document has esignatur Agreement-ID: 7fa09fdb6e4a6e4cqwgngt224422103605069021
Management Commentary. The Smallbrooks business model is based on long-term relationships and a subscription structure that provides stable, recurring revenue instead of large upfront payments. The increased expenses for Smallbrooks and the natural delay in recurring revenue combined with the end of the grant from Innovation Fund Denmark means that Smallbrooks, overall, contributes negatively to this year’s result, and even more so compared to last year. However, Smallbrooks is part of a long-term strategy and continues to contribute very positively to our expectations for the future. The gross profit for the year is 0.8 million DKK compared to 1.5 million DKK last year. The result from ordinary activities after tax is -2.4 million DKK compared to -0.9 million DKK last year. The management considers the results satisfactory. The fall in gross profit is due to the grant from Innovation Fund Denmark, which benefited the 2018 accounts but ended in 2019 The further fall in the ordinary result is caused by an increase in salary expenses due to the increased investments in Smallbrooks.
Management Commentary. The most important milestones for 2020 are: • The lending business is and remains cash-flow positive. • Six new Smallbrooks customer contracts are signed. • Break-even for the entire company is reached by the end of the year unless we decide to accelerate growth by investing further in Smallbrooks (and unless the current COVID-19 situation negatively impacts the business, although we do not expect this)
Management Commentary. We landed two new customers in Q1 prior to the Covid-19 shutdown, and a thirdy customer in Q4. This is half of the six customers we budgeted for, but nonetheless a satisfactory result considering the unusual situation. The existing customers have done a great job in ordering new IT features, and regardless of the Covid-19 situation we have therefore been able to increase the revenue from Smallbrooks substantially compared to last year. Indeed, in terms of revenue, Q4 was the best quarter in the history of Smallbrooks. Two new projects were undertaken in 2020: First, we received funding from the Danish Business Authority for the project “Simple Crowdfunding” in which we will create a very simple setup for getting a crowdfunding platforms using a CMS version of the Smallbrooks solution and based on Xxxxxxx'x existing legal setup and license with the Danish FSA. The project will lower the barrier of entry for getting into crowdfunding, and we believe that this will eventually be a way to onboard new Smallbrooks customers. Second, we landed a contract for a crowdsourcing platform, which we will create for a Danish research institution. The concept of crowdsourcing plays very well together with crowdfunding, so we believe that this project will add some important new features to the Smallbrooks solution that can be offered to many other customers. Overall, we continue to see Smallbrooks as a very scalable part of the business with a very large potential. The business model is based on long-term relationships and a subscription structure that provides stable, recurring revenue instead of large upfront payments. Thus, Smallbrooks is part of a long-term strategy and continues to contribute very positively to our expectations for the future. The gross profit for the year is 1,9 million DKK compared to 0,6 million DKK last year. The result from ordinary activities after tax is -2.0 million DKK compared to -2.4 million DKK last year. The management considers the results to be as expected and satisfactory, considering the increased salary expenses due to the investments in Smallbrooks. In Q4, 2020 the company received a loan from the Danish Growth Fund. The loan was offered as part of a Covid-19 package and is on very favourable terms. During 2021 a further capital increase has been planned, both from a VC and from a new campaign on the equity crowdfunding platform Funderbeam. Overall the liquidity situation looks good. The revenue streams that can be foreseen both fr...
Management Commentary. “The intended acquisition of Aleafia expands our footprint to the largest federally legal cannabis market globally," said Xxxx Xxxxxx, CEO and Director of RWB. “Combining our award-winning brands and IP with Aleafia’s proven cultivation, manufacturing, and distribution capabilities, creates one of the most dynamic cross border companies in the industry. We continue to focus on delivering significant value to our shareholders and believe this transaction aligns with that commitment.” “The potential acquisition of Aleafia represents a transformative milestone for RWB. It provides a well-established distribution beachhead for RWB and its premium Platinum brand into the Canadian market, opens up the larger U.S. market to Aleafia’s select brands through RWB’s distribution and retail channels, and provides both companies with an opportunity to mutually leverage their respective competencies in the areas of cultivation, procurement, product development, and sales and marketing,” said Xxxxx Xxxxxx, CFO of RWB. “Working together, we believe RWB and Aleafia are well positioned to capitalize on value-added synergies that will ultimately enhance the profitability of the Combined Company.” (1) “The Canadian cannabis market has the potential to be a dynamic industry and is rapidly experiencing consolidation. In 2022 and 2023, Aleafia has achieved significant milestones including growing the Divvy brand through expansion into five provincial markets and bolstering its international business through sales into Europe and Australia. The Proposed Transaction is a next step in the Aleafia story as it enhances our size and scale which is a critical requirement to compete in this market and provides Aleafia improved access to capital to execute on our strategic growth opportunities,” said Xxxxxx Xxxxxx, Chief Executive Officer of Aleafia. “This is a prime opportunity for Aleafia to merge with a multi-state operator. The Proposed Transaction would recapitalize Aleafia’s balance sheet and provide our shareholders with access to a larger market capitalization and exposure to the U.S. recreational and medical cannabis markets,” said Xxxx Xxxx, Chief Financial Officer of Aleafia. “The improved financial flexibility and capacity of the Combined Company will enhance the ability to execute on organic and acquisitive growth strategies,” continued Mr. Xxxx. Key Business and Transaction Highlights(1) · Enhanced Size & Scale: Aleafia generated C$40 million in revenue in the twelve months ...
Management Commentary. “This is a major transition point for the Company, as we continue to execute our plans, allowing us to significantly reduce our debt while right-sizing our operations in Quebec without disruption,” commented Xxxx Xxxxxxxxx, TGOD’s CEO and Interim CFO. “Furthermore, we are pleased to be in position to provide for potential future growth in cultivation in Quebec through the leaseback of an appropriate portion of the Quebec Facility. Our portfolio of products is receiving positive reviews across the country and we look forward to providing Quebec with locally grown products, as demand continues to increase. Our balance sheet is being strengthened through the sale of excess assets and the elimination of term debt, and we expect annualized net cashflow savings of approximately $4 million in interest and overhead costs. This sets the foundation for the Company to take advantage of other growth opportunities in Canada and the United States,” added Bovingdon. • Gross Purchase Price of $27 million, paid on Closing in cash from funds deposited into escrow by the Purchaser. • Additional $5.7 million deposit to be refunded to Medican upon completion of the transfer to the Purchaser of a utility pricing agreement with Hydro Quebec, to occur concurrently with Closing. • Medican will be provided with an initial two-year lease for 80,000 square feet, representing cultivation, processing and manufacturing spaces in the Quebec Facility, at an annual rate of $12.50 per square foot. • In addition, Medican will enter into a three-year lease and cannabis supply agreement with the Purchaser, commencing after the initial two-year lease, for approximately 80,000 square feet of the Quebec Facility, whereby Medican will pay $8.75 per square foot per year for the processing and manufacturing space only and will pay the Purchaser a net amount based on the wholesale value of bulk dried cannabis that Medican produces from the growing premises in lieu of rent for that space. This will be a net amount based on bulk wholesale market prices at that time less all costs of cultivation and costs to process to point of sale of bulk dried cannabis. Medican will maintain ownership of its organic cannabis produced for sale into the retail markets. • Concurrent with Closing, TGOD will pay approximately $31.8 million to its senior lender in full and complete settlement of all its obligations to such lender. • The APS closing is subject to usual and customary conditions for such transactions. • BMO C...
